太极集团(600129.SH)：公司股东拟被吸收合并

Core Viewpoint - Taiji Group (600129.SH) announced the planned absorption merger of its wholly-owned subsidiary, Chongqing Taiji Medicinal Plant and Animal Resources Development Co., Ltd., with another wholly-owned subsidiary, Chongqing Fuling Xilan Biotechnology Co., Ltd. This merger will not change the controlling shareholder or actual controller of the company and will not affect its independence or governance structure [1] Group 1 - The merger involves the absorption of Xilan Biotechnology, which will lead to the cancellation of Xilan's legal entity [1] - After the merger, the number of shares held by the resource company will increase from 367,271 shares to 12,262,565 shares, representing 2.224% of the company's total share capital [1] - The merger is stated to have no impact on the company's personnel, assets, finances, business, or operational independence [1]